Literature DB >> 6629965

Influences of exercise intensity, age, and medication on resting systolic blood pressure of SHR populations.

C M Tipton, R D Matthes, K D Marcus, K A Rowlett, J R Leininger.   

Abstract

The influence of exercise training on the resting caudal arterial blood pressures (RBP) of hypertensive rats is unclear despite numerous investigations by different investigators. To determine whether RBP values were influenced by the intensity and the initial age of the animal at the time of training, several studies were undertaken that involved more than 100 rats. When male and female rats were endurance trained for 24 wk at an O2 consumption in excess of 75% of their maximum (Vo2 max), RBP results from nontrained (NT) or trained (T) animals were not significantly different even though at several time periods the T animals had higher resting pressures. However, when exercising rats at an intensity level representing 40-60% of their Vo2 max, the T groups had consistently lower RBP than their NT controls during the majority of the experimental time periods. In addition exercising young (2-3 wk old) hypertensive-prone rats at a moderate intensity was associated with lower RBP within 4-6 wk after the initiation of training; however, exercise training could not normalize RBP. Reduced dosages (85% of normal) of antihypertensive medication, when combined with moderate training, was also associated with lower and "normal" RBP in male but not female rats. We conclude that moderate exercise at an early age when combined with subnormal dosages of antihypertensive medication holds promise for the normalization of RBP in male hypertensive rats of a genetic origin.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6629965     DOI: 10.1152/jappl.1983.55.4.1305

Source DB:  PubMed          Journal:  J Appl Physiol Respir Environ Exerc Physiol        ISSN: 0161-7567


  14 in total

Review 1.  The role of exercise training in the treatment of hypertension: an update.

Authors:  J M Hagberg; J J Park; M D Brown
Journal:  Sports Med       Date:  2000-09       Impact factor: 11.136

2.  Postconditioning hormesis put in perspective: an overview of experimental and clinical studies.

Authors:  F A C Wiegant; H A B Prins; R Van Wijk
Journal:  Dose Response       Date:  2010-08-12       Impact factor: 2.658

3.  Systemic arterial blood pressure responses of stroke-prone spontaneously hypertensive rats to treadmill exercise.

Authors:  O Kashimura; S Igawa
Journal:  Environ Health Prev Med       Date:  1996-10       Impact factor: 3.674

4.  Effect of exercise training on aortic collagen content in spontaneously hypertensive rats (SHR).

Authors:  M Higuchi; I Hashimoto; K Yamakawa
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1985

5.  Physical exercise alleviates ADHD symptoms: regional deficits and development trajectory.

Authors:  Trevor Archer; Richard M Kostrzewa
Journal:  Neurotox Res       Date:  2011-08-18       Impact factor: 3.911

6.  Effects of acute exercise and prolonged exercise training on blood pressure, vasopressin and plasma renin activity in spontaneously hypertensive rats.

Authors:  F Ghaemmaghami; A M Allevard; J Fareh; G Geelen; C Gharib
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1991

7.  Exercise training enhanced the expression of myocardial proteins related to cell protection in spontaneously hypertensive rats.

Authors:  Claude Lajoie; Angelino Calderone; Louise Béliveau
Journal:  Pflugers Arch       Date:  2004-10       Impact factor: 3.657

8.  Blood pressure and sympathetic activity in spontaneously hypertensive rats during food restriction.

Authors:  K Gradin; B Persson
Journal:  J Neural Transm Gen Sect       Date:  1990

Review 9.  Physical activity in human hypertension. A mechanisms approach.

Authors:  W L Kenney; E J Zambraski
Journal:  Sports Med       Date:  1984 Nov-Dec       Impact factor: 11.136

Review 10.  Exercise Dose in Clinical Practice.

Authors:  Meagan M Wasfy; Aaron L Baggish
Journal:  Circulation       Date:  2016-06-07       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.